Jiangsu Aoyang Health Industryltd Management
Management criteria checks 3/4
We currently do not have sufficient information about the CEO.
Key information
Jing Li
Chief executive officer
CN¥451.8k
Total compensation
CEO salary percentage | n/a |
CEO tenure | 3.1yrs |
CEO ownership | n/a |
Management average tenure | no data |
Board average tenure | 3.9yrs |
Recent management updates
Recent updates
Jiangsu Aoyang Health Industry Co.ltd.'s (SZSE:002172) Share Price Boosted 36% But Its Business Prospects Need A Lift Too
Dec 16We Believe Jiangsu Aoyang Health Industryltd's (SZSE:002172) Earnings Are A Poor Guide For Its Profitability
Sep 04There's No Escaping Jiangsu Aoyang Health Industry Co.ltd.'s (SZSE:002172) Muted Revenues
Feb 29CEO
Jing Li (43 yo)
3.1yrs
Tenure
CN¥451,800
Compensation
Ms. Jing Li is Vice Chairman & GM of Jiangsu Aoyang Health Industry Co.ltd. Ms. Li was Vice Chairman of Jiangsu Aoyang Health Industry Co.ltd. Ms. Li was Non-Independent Director of Jiangsu Aoyang Health I...
Board Members
Name | Position | Tenure | Compensation | Ownership |
---|---|---|---|---|
Vice Chairman & GM | 3.1yrs | CN¥451.80k | no data | |
CFO & Non-Independent Director | 6.2yrs | CN¥371.70k | 0.049% CN¥ 1.2m | |
Deputy GM & Non-Independent Director | 6.2yrs | CN¥421.80k | no data | |
Secretary of the Board & Non-Independent Director | 5.3yrs | CN¥321.80k | no data | |
Chairman of the Board of Directors | no data | CN¥602.00k | 2.24% CN¥ 53.2m | |
Non-Independent Director | 9.2yrs | no data | no data | |
Non-Employee Supervisor | 6.2yrs | no data | 0.020% CN¥ 465.0k | |
Independent Director | 3.1yrs | CN¥60.00k | no data | |
Independent Director | 3.1yrs | CN¥60.00k | no data | |
Non-Employee Supervisor | 3.1yrs | no data | no data | |
Independent Director | 3.1yrs | CN¥60.00k | no data | |
Employee Supervisor | 3.9yrs | no data | no data |
3.9yrs
Average Tenure
50.5yo
Average Age
Experienced Board: 002172's board of directors are considered experienced (3.9 years average tenure).
Company Analysis and Financial Data Status
Data | Last Updated (UTC time) |
---|---|
Company Analysis | 2025/01/06 22:04 |
End of Day Share Price | 2025/01/06 00:00 |
Earnings | 2024/09/30 |
Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
Package | Data | Timeframe | Example US Source * |
---|---|---|---|
Company Financials | 10 years |
| |
Analyst Consensus Estimates | +3 years |
|
|
Market Prices | 30 years |
| |
Ownership | 10 years |
| |
Management | 10 years |
| |
Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiangsu Aoyang Health Industry Co.ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
Analyst | Institution |
---|---|
Hanfeng Wang | China International Capital Corporation Limited |
Qiushi Qi | China Minzu Securities |
Guan Peng Gao | CSC Securities (HK) Ltd. |